These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6698988)

  • 1. Eosinophils as the source of uterine nuclear type II estrogen binding sites.
    Lyttle CR; Medlock KL; Sheehan DM
    J Biol Chem; 1984 Mar; 259(5):2697-700. PubMed ID: 6698988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine type II estrogen-binding sites are not of eosinophil origin.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    J Biol Chem; 1986 Jan; 261(1):142-6. PubMed ID: 3941067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
    Lyttle CR; Teuscher C; Medlock KL; Sheehan DM
    Endocrinology; 1989 Nov; 125(5):2773-9. PubMed ID: 2792007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
    Markaverich BM; Roberts RR; Finney RW; Clark JH
    J Biol Chem; 1983 Oct; 258(19):11663-71. PubMed ID: 6619136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen dependent induction of low affinity binding sites in the nuclear fraction of rat uterus.
    De Hertogh R; Ekka E; Vanderheyden I
    J Steroid Biochem; 1986 Jun; 24(6):1171-7. PubMed ID: 3736044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin.
    Markaverich BM; Shoulars K; Brown MA
    Steroids; 2001 Sep; 66(9):707-19. PubMed ID: 11546559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the estrogen receptors in the uterine and blood eosinophil leukocytes.
    Tchernitchin A; Tchernitchin X
    Experientia; 1976 Oct; 32(10):1240-2. PubMed ID: 987923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the calf uterine estrogen receptor with acceptor sites in heterologous chicken target cell nuclei.
    de Boer W; Snippe L; Ab G; Gruber M
    J Steroid Biochem; 1986 Apr; 24(4):825-33. PubMed ID: 3702460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
    Markaverich BM; Roberts RR; Alejandro MA; Johnson GA; Middleditch BS; Clark JH
    J Steroid Biochem; 1988; 30(1-6):71-8. PubMed ID: 3386279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of uterine nuclear type II estrogen binding sites in estrogen treated rats.
    Sheehan DM; Medlock KL; Lyttle CR
    J Steroid Biochem; 1986 Jul; 25(1):37-43. PubMed ID: 3747514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
    Bulger WH; Kupfer D
    Mol Pharmacol; 1982 May; 21(3):533-7. PubMed ID: 7110114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated changes in nuclear binding of rat uterine estradiol receptor complexes.
    Chuknyiska RS; Haji M; Foote RH; Roth GS
    Endocrinology; 1985 Feb; 116(2):547-51. PubMed ID: 3967620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of estrogen receptors in granulosa cells of immature rats.
    Tonetta SA; Ireland JJ
    Steroids; 1983 Oct; 42(4):427-40. PubMed ID: 6679947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol regulation of uterine nucleolar estradiol binding sites.
    Whelly SM
    Biochim Biophys Acta; 1986 Feb; 880(2-3):179-88. PubMed ID: 2417631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.